powered by Federated Media

Glaxosmithkline

FDA approves once-a-day inhaler from Glaxo

Glaxo, a leader in respiratory medicine, already sells the asthma treatment Advair, its best-selling product with more than $4 billion in sales per year.

Save the Children, drug co. GSK in new partnership

Witty said GSK, one of the world's leading drug makers, has been working to increase expanded access to medicine over the last five to six years, an approach he said has high shareholder support.

News Summary: Vaccine project aids poor countries

TEAMWORK: Drugmakers Merck and GlaxoSmithKline are working with the Global Alliance for Vaccines and Immunization to provide hugely discounted cervical cancer vaccines to millions of girls in poor...

Glaxo donates NC Wyeth painting to Philly museum

Pharmaceutical giant GlaxoSmithKline has donated a painting with a mysterious past to the Philadelphia Museum of Art.

Europe dents Glaxo's Q4 profits

U.K. pharmaceutical company GlaxoSmithKline is looking to cut costs further this year as it reported a sharp drop in fourth-quarter profit on the back of problems in Europe.

Advertisement

Partners

Elan enters $1B royalty deal with Theravance

The deal announced Monday will give Elan 21 percent of the future royalties that South San...

Jos. A. Bank Clothiers, Tesla, Overstock

Irish drugmaker Elan plans to pay $1 billion for future royalties from four respiratory...

Stocks drop despite rise in retail sales

Elan Corp. will pay $1 billion for the right to future royalties from respiratory treatments...

Blogs

Analysts: Microsoft Has Big Potential and 3 More Research Notes to Browse

The firm expects other bidders to emerge should Elan back out of its deal with Theravance, and...

Will Influenza A H7N9 Generate Opportunities For Pharma?

OB), Gilead sciences (GILD) and GSK will see a massive increase in sales since the prevention is...

She Went to Pieces (live) Song Lyrics, Music Video

The following Youtube video has been added by our user community for this Glaxo Babies song:

Web

BRIEF-GSK makes regulatory submission for umeclidinium monotherapy in U.S.

BRIEF-GSK makes regulatory submission for umeclidinium monotherapy in U.S.

Impax, GSK end Parkinson's disease partnership

(Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on...

UPDATE 1-FDA raises concerns on seizure drug of Valeant, Glaxo

UPDATE 1-FDA raises concerns on seizure drug of Valeant, Glaxo